July 1, 2024

Menstrual Cramps Treatment is Driven by Growing Demand for Minimally Invasive Options

Menstrual cramps treatment products aim to relieve the pain caused due to menstrual cramps. Menstrual cramps, also known as dysmenorrhea, are characterized by pain in the lower abdomen, which may radiate to the lower back, upper thighs, and sometimes the legs. Various treatment options are available ranging from oral contraceptives, non-steroidal anti-inflammatory drugs (NSAIDs), acupuncture, transcutaneous electrical nerve stimulation (TENS), and thermal therapies. In recent times, minimally invasive options such as menstrual discs and cups are gaining popularity among women as they provide pain relief without the need for prescription medications.

The global Menstrual Cramps Treatment Market is estimated to be valued at US$ 652.3 Mn in 2023 and is expected to exhibit a CAGR of 4.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends: One of the key trends in the menstrual cramps treatment market is the growing popularity of menstrual discs. Menstrual discs are soft, flexible discs made of medical-grade silicone that are inserted into the vaginal canal where it rests underneath the cervix creating a seal. Compared to tampons and pads, menstrual discs prevent leakage and are more comfortable for women during their periods. They allow natural menstrual blood flow while blocking it from leaking. Being discreet and ease of use without requiring frequent changes are elevating the demand for menstrual discs.

Porter’s Analysis
Threat of new entrants: Low as the established players already have strong brand recognition and distribution networks in place. However, new startups can disrupt the market with innovative products.
Bargaining power of buyers: High as there are many established as well as new players offering comparable products. Buyers can negotiate on price.
Bargaining power of suppliers: Moderate as some key raw materials have limited sources of supply.
Threat of new substitutes: Moderate as new alternative treatment options constantly emerge but established treatment regimens are difficult to replace.
Competitive rivalry: High due to presence of many international and local players competing on basis of product quality, price and effective marketing.

Key Takeaways
The global menstrual cramps treatment market is expected to witness high growth. The North America region currently dominates the market due to high awareness levels and technological advancements in treatment modalities.

Regional analysis: North America is expected to maintain its dominance in the global menstrual cramps treatment market during the forecast period. This is majorly attributed to higher healthcare expenditure, advanced healthcare infrastructure, and growing awareness among women regarding menstrual cramps treatment options in the region.

Key players: Key players operating in the menstrual cramps treatment market are Stryker Corporation, SATELEC (Actongroup), Surgiform Innovative Surgical Products, Allergan (Abbvie) Luminera, Implantech, Koken, ANTHONY PRODUCTS INC., NOUVAG, Sihuan Pharmaceutical Holdings Group Ltd., and Other. Stryker Corporation offers versatile and advanced products portfolio catering to gynecology and obstetrics procedures.

*Note:

  1. Source: Coherent Market Insights, Public sources, Desk research

2. We have leveraged AI tools to mine information and compile it